|
rs603965
|
|
Glioma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Our findings suggested that CCND1 rs603965 polymorphism may serve as a potential genetic biomarker of brain tumor, especially for glioma.
|
30972946 |
2019 |
|
rs603965
|
|
Glioma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Polymorphism in rs603965 within CCND1 gene and rs1346787 within EFEMP1 gene and its gene- gene interaction were associated with increased glioma risk.
|
28380465 |
2017 |
|
rs603965
|
|
Meningioma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Moreover, in stratified analyses by type of disease, we noticed that the rs603965 polymorphism was significantly associated with the susceptibility to glioma, but such positive results were not detected in pituitary adenoma or meningioma.
|
30972946 |
2019 |
|
rs603965
|
|
Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Additionally, a significant association with tumor grade was also observed for the rs603965 polymorphism in G versus A (allele comparison, p = 0.02, OR = 0.74, 95% CI 0.59-0.95, I<sup>2</sup> = 26%).
|
30972946 |
2019 |
|
rs603965
|
|
Brain Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
Our findings suggested that CCND1 rs603965 polymorphism may serve as a potential genetic biomarker of brain tumor, especially for glioma.
|
30972946 |
2019 |
|
rs603965
|
|
Adult Meningioma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Moreover, in stratified analyses by type of disease, we noticed that the rs603965 polymorphism was significantly associated with the susceptibility to glioma, but such positive results were not detected in pituitary adenoma or meningioma.
|
30972946 |
2019 |
|
rs603965
|
|
Meningioma, benign, no ICD-O subtype
|
|
0.010 |
GeneticVariation
|
BEFREE |
Moreover, in stratified analyses by type of disease, we noticed that the rs603965 polymorphism was significantly associated with the susceptibility to glioma, but such positive results were not detected in pituitary adenoma or meningioma.
|
30972946 |
2019 |
|
rs603965
|
|
Colon Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
For the rs603965 polymorphism of the CCND1 gene, we observed a protection effect for the colon cancer location under the dominant model (OR=0.49, P=0.0477).
|
27755946 |
2016 |
|
rs603965
|
|
Malignant tumor of colon
|
|
0.010 |
GeneticVariation
|
BEFREE |
For the rs603965 polymorphism of the CCND1 gene, we observed a protection effect for the colon cancer location under the dominant model (OR=0.49, P=0.0477).
|
27755946 |
2016 |
|
rs603965
|
|
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
|
0.010 |
GeneticVariation
|
BEFREE |
The aim of this meta-analysis is to generate large-scale evidence to determine the degree to which common Cyclin D1 (CCND1) G870A (dbSNP: rs603965) and xeroderma pigmentosum group C (XPC) Ala499Val (dbSNP: rs2228000) polymorphisms are associated with susceptibility to bladder cancer.
|
24264314 |
2014 |
|
rs603965
|
|
Bladder Neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
The aim of this meta-analysis is to generate large-scale evidence to determine the degree to which common Cyclin D1 (CCND1) G870A (dbSNP: rs603965) and xeroderma pigmentosum group C (XPC) Ala499Val (dbSNP: rs2228000) polymorphisms are associated with susceptibility to bladder cancer.
|
24264314 |
2014 |
|
rs603965
|
|
Malignant neoplasm of urinary bladder
|
|
0.010 |
GeneticVariation
|
BEFREE |
The aim of this meta-analysis is to generate large-scale evidence to determine the degree to which common Cyclin D1 (CCND1) G870A (dbSNP: rs603965) and xeroderma pigmentosum group C (XPC) Ala499Val (dbSNP: rs2228000) polymorphisms are associated with susceptibility to bladder cancer.
|
24264314 |
2014 |
|
rs603965
|
|
Carcinoma of bladder
|
|
0.010 |
GeneticVariation
|
BEFREE |
The aim of this meta-analysis is to generate large-scale evidence to determine the degree to which common Cyclin D1 (CCND1) G870A (dbSNP: rs603965) and xeroderma pigmentosum group C (XPC) Ala499Val (dbSNP: rs2228000) polymorphisms are associated with susceptibility to bladder cancer.
|
24264314 |
2014 |
|
rs603965
|
|
Lymphoma, Non-Hodgkin
|
|
0.010 |
GeneticVariation
|
BEFREE |
The cyclin D1 (CCND1) splice variant G870A (rs603965) increased NHL risk (OR(AA) = 1.4, 95% CI = 1.1-1.8, P-trend = 0.021), which was consistent for four B-cell subtypes.
|
16783567 |
2006 |